暂无数据
暂无内容
暂无数据
暂无数据
暂无数据
Quoin Pharmicals 将于 2024 年 5 月 9 日公布2024年第一季度财务业绩
弗吉尼亚州阿什本,2024年5月2日(GLOBE NEWSWIRE)——Quoin Pharmicals Ltd.(纳斯达克股票代码:QNRX)(“公司” 或 “Quoin”),一家专注于稀有和孤儿药物的临床阶段专业制药公司
Quoin Pharmaceuticals05/02 00:00 (美东)
Maxim Group 维持在 Quoin Pharmicals 的买入状态
Maxim Group 维持在 Quoin Pharmicals 的买入状态
道琼斯03/15 11:25 (美东)
快讯 | Maxim集团维持对Quoin Pharmicals的买入,将目标股价下调至4美元
Moomoo 24/703/15 11:15 (美东)
Quoin 制药分析师评级
日期上行/下行分析师公司目标股价变动评级变动之前/当前评级 2024 年 3 月 15 日 327.76% Maxim Group 15 美元 → 4 美元维持买入 2022年7月9日买入 2038.81% 联盟全球合作伙伴 → 20 美元 I
Benzinga03/15 11:13 (美东)
Quoin Pharmicals, Ltd.(纳斯达克股票代码:QNRX)2023年第四季度财报电话会议记录
Yahoo Finance03/15 10:52 (美东)
财报电话会议:Quoin Pharmicals报告第四季度进展和展望
Investing03/14 21:26 (美东)
MDR81 : I stuck at 1.5 average, I don't have much confident ER positive.. what is your advice @Mcsnacks H Tupack
taijahmed75 MDR81: It’s a blood bath today, I didn’t expect that it will come down below.90, I’m bit tensed now. @Mcsnacks H Tupack @Trytosaveabit can you pls give us your valuable input here?
PortoCall : I saw their share offering - what’s your input on that move? Wondering if I should take it or hold it.
Rockaphobic楼主 PortoCall:
ASHBURN, Va. - Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX), a specialty pharmaceutical company, has announced the pricing of a public offering aimed at raising approximately $6.5 million. The offering includes 4,062,500 shares, each represented by American Depositary Shares (ADS), and warrants for purchasing additional shares.
The combined purchase price for one ADS and associated Series D and Series E warrants is $1.60. These warrants, exercisable immediately upon issuance, are priced at $1.60 per share and will expire two and five years from the date of issuance, respectively. The company expects the offering to close on or about March 7, 2024, subject to standard closing conditions.
Rockaphobic楼主 : On March 13th, they'll be releasing their earnings report. My guess is that it will be all the fuel this will need to take a trip to the . Hope your are packed. The 14th will come fast.
暂无数据
暂无数据